Karen Meliksetyan, Board Member of Armenian Hematology Association, Head of the Bone Marrow Transplant Program at Yeolyan Hematology Center, shared a post on Facebook:
“It is a tremendous honor to be a co-author on recent publication in The New England Journal of Medicine.
I am incredibly proud to have been part of this research journey alongside such a dedicated group of colleagues. A special congratulations to Jerald Radich for his phenomenal leadership on this project.
A special and deep thanks to:
The Max Foundation: For your visionary leadership, the TFR Support Program, and for providing the life-changing resources and diagnostics that make safe treatment cessation a reality for patients worldwide
Yeolyan Hematology and Oncology Center, to my colleagues and our institution – thank you for your clinical excellence, rigorous monitoring, and unwavering commitment to our patients’ care.”
Title: Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries
Authors: Alicia Annamalay, Inés García González, Colin Forsyth, Isaac Jenkins, Mercedes Arteaga, Nicholas A. Othieno-Abinya, Chirag Desai, Flora Duarte, Vadavattath P. Gangadharan, Sadashivudu Gundeti, Hemant Malhotra, Pankaj Malhotra, Karen Meliksetyan, Rafael Mojica, José Zarza, Juan Miguel Sabonge, Anyelis Lucia Santana, Amha Gebremedhin, Rafael Orellana Martínez, Maritza Martínez Miranda, Marta Griselda Lima Valencia, Pat Garcia-Gonzalez and Jerald Radich.
Other articles featuring Karen Meliksetyan on OncoDaily.